VolitionRx GC has 7,003 shares withheld for taxes

VolitionRx Ltd reported a Form 4 for General Counsel of Volition Diagnostics, Nicholas Plummer, reflecting a routine tax-related share disposition.

Accepted by SEC EDGAR 03/19/2026 - 04:30 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

VolitionRx Ltd reported a Form 4 for General Counsel of Volition Diagnostics, Nicholas Plummer, reflecting a routine tax-related share disposition. 7,003 shares of common stock were retained by VolitionRx for cancellation to satisfy his tax withholding obligations upon settlement of 14,900 restricted stock units. No shares were sold by Plummer or the company in this transaction. Following the cancellation, Plummer holds 407,267 shares of VolitionRx common stock directly.

Insider Trade Summary

Exercise Price or Tax Liability: 7,003 shares

Exercise Price or Tax Liability 1 txn

Insider Plummer Nicholas

Role GC - Volition Diagnostics

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	7,003	$0.19	$1K

Holdings After Transaction: Common Stock — 407,267 shares (Direct)

Footnotes (1)

1. F1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 14,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VolitionRx (VNRX) report for Nicholas Plummer?

VolitionRx reported that General Counsel Nicholas Plummer had 7,003 shares of common stock withheld and cancelled to cover tax obligations on the settlement of 14,900 restricted stock units. This was a tax-withholding event, not an open-market trade.

Was the VolitionRx (VNRX) Form 4 transaction an insider sale of shares?

No, the Form 4 states that no shares were sold by Nicholas Plummer or VolitionRx. Instead, 7,003 shares were retained by the company and cancelled solely to satisfy Plummer’s tax withholding obligations upon settlement of his restricted stock units.

How many VolitionRx (VNRX) shares does Nicholas Plummer hold after this Form 4?

After the tax-withholding cancellation, Nicholas Plummer directly holds 407,267 shares of VolitionRx common stock. The reported transaction only reduced his holdings by the 7,003 shares cancelled to cover taxes on vested restricted stock units.

What triggered the tax-withholding share cancellation at VolitionRx (VNRX)?

The cancellation was triggered by the settlement of 14,900 restricted stock units awarded to Nicholas Plummer. To satisfy his tax withholding obligations on this vesting event, 7,003 shares of common stock were retained by VolitionRx for cancellation instead of being delivered.

Does the VolitionRx (VNRX) Form 4 indicate a trading decision by Nicholas Plummer?

The Form 4 reflects a tax-withholding disposition, not a discretionary trading decision. Shares were automatically retained and cancelled by VolitionRx to pay taxes on vested restricted stock units, with no open-market buying or selling by Plummer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plummer Nicholas

(Last) (First) (Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON NEVADA 89014

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC - Volition Diagnostics

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		F		7,003(1)	D	$0.19	407,267	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 14,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

Remarks:

	/s/ Nicholas Plummer	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)